# US 2015/0144783 A1 · Glycopeptide analyzer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0144783 A1
- Document ID: US20150144783A1
- Status: Published application
- Kind: A1
- Application number: 14/553,311
- Filed: 2014-11-25
- Published: 2015-05-28
- Earliest claimed: 2013-11-27
- Assignees: Shimadzu Corporation
- Applicants: Shimadzu Corporation
- Inventors: Masaki MURASE
- Web page: https://patentgrep.com/patent/US20150144783A1

## CPC

- H01J 49/009: {Spectrometers having multiple channels, parallel analysis}
- G01N 33/6842: {Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins}
- G01N 33/6851: {Methods of protein analysis involving laser desorption ionisation mass spectrometry}
- H01J 49/40: Time-of-flight spectrometers (H01J49/36 takes precedence)
- H01J 49/42: Stability-of-path spectrometers, e.g. monopole, quadrupole, multipole, farvitrons
- C12Q 1/6872: involving mass spectrometry
- C12Q 2565/627: being a mass spectrometer
- C40B 20/08: Direct analysis of the library members per se by physical methods, e.g. spectroscopy
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The same sample S is analyzed using an ion-trap (IT) mass spectrometer section 11 in which ions are captured in an ion trap before mass spectrometry and a time-of-flight (TOF) mass spectrometer section 12 in which ions generated from the sample are directly subjected to mass spectrometry. A mass spectrum creator 21 creates an IT mass spectrum and a TOF mass spectrum from the measured results. A glycopeptide detector 23 detects fragment ion peaks related to neutral loss of sugars from the IT mass spectrum as well as peaks corresponding to intact molecular ions from the TOF mass spectrum, and furthermore, detects peaks common to the two spectra as glycopeptide ions. A quantitative analyzer 24 determines relative quantities of glycoforms of the glycopeptide based on the TOF mass spectrum. A structural analyzer 25 analyzes the structure of the glycopeptide using the result of an MSn analysis of the sample S.

## Claims

### Claim 1

A glycopeptide analyzer for performing an analysis on a glycoform mixture of a glycoprotein or glycopeptide, comprising:
a) an ion-trap mass spectrometer section having an ion trap capable of temporarily capturing ions generated from a sample and fragmenting the captured ions, the ion-trap mass spectrometer section being configured to separate the ions according to their mass to charge ratios by the ion trap or another mass separator and to detect the separated ions;
b) a time-of-flight mass spectrometer section for introducing ions generated from a sample into a flight space, for separating the ions according to their mass-to-charge ratios within the flight space, and for detecting the separated ions;
c) a glycopeptide detector section for detecting peaks related to dissociation of a portion or the entirety of glycan on a first MS1 spectrum created based on a result of a measurement by the ion-trap mass spectrometer section, for detecting molecular ion peaks on a second MS1 spectrum created based on a result of a measurement by the time-of-flight mass spectrometer section, and for finding glycopeptide ions from common peaks located on both MS1 spectra;
d) a quantitative analyzer section for determining, for the glycopeptide ion detected by the glycopeptide detector section, a relative quantity of a glycoform using a relative peak intensity on the second MS2 spectrum; and
e) a structural analyzer section for performing, for the glycopeptide ion detected by the glycopeptide detector section, a structural analysis of a glycoform using, at least, the result of an MSn analysis (where n is an integer equal to or greater than two) performed by the ion-trap mass spectrometer section.

### Claim 2 (depends on 1)

The glycopeptide analyzer according to claim 1, wherein:
the ion-trap mass spectrometer section is a matrix-assisted laser desorption ionization ion-trap time-of-flight mass spectrometer, and the time-of-flight mass spectrometer section is a matrix-assisted laser desorption ionization liner time-of-flight mass spectrometer.

### Claim 3 (depends on 1)

The glycopeptide analyzer according to claim 1, wherein:
the glycopeptide detector section analyzes the first MS1 spectrum by de novo sequencing to detect each peak which is likely to be a fragment ion of glycopeptide ion from which a portion or the entirety of glycan has been dissociated as a neutral loss.

### Claim 4 (depends on 1)

The glycopeptide analyzer according to claim 1, wherein:
the glycopeptide detector section detects each significant peak which is located on the second MS1 spectrum and whose signal intensity exceeds a threshold, on an assumption that such a peak corresponds to an ion originating from an intact molecule.
